These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy. Kitze B, Usuku K, Izumo S, Nakamura M, Shiraki H, Ijichi S, Yashiki S, Fujiyoshi T, Sonoda S, Osame M. J Neurol; 1996 May; 243(5):393-400. PubMed ID: 8741079 [Abstract] [Full Text] [Related]
3. Comparative analysis of the antibody response to the HTLV-I gag and env proteins in HTLV-I asymptomatic carriers and HAM/TSP patients: an isotype and subclass analysis. Dekaban GA, King EE, Arp J, Palker TJ, Rice GP. Scand J Immunol; 1994 Aug; 40(2):171-80. PubMed ID: 8047838 [Abstract] [Full Text] [Related]
4. Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals. Enose-Akahata Y, Abrams A, Massoud R, Bialuk I, Johnson KR, Green PL, Maloney EM, Jacobson S. Retrovirology; 2013 Feb 13; 10():19. PubMed ID: 23405908 [Abstract] [Full Text] [Related]
6. Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica. Enose-Akahata Y, Abrams A, Johnson KR, Maloney EM, Jacobson S. Blood; 2012 Mar 22; 119(12):2829-36. PubMed ID: 22318200 [Abstract] [Full Text] [Related]
7. Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load. Kira J, Nakamura M, Sawada T, Koyanagi Y, Ohori N, Itoyama Y, Yamamoto N, Sakaki Y, Goto I. J Neurol Sci; 1992 Jan 22; 107(1):98-104. PubMed ID: 1578240 [Abstract] [Full Text] [Related]
9. Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP. Nakamura M, Kuroki M, Kira J, Itoyama Y, Shiraki H, Kuroda N, Washitani Y, Nakano S, Nagafuchi S, Anzai K. J Neuroimmunol; 1991 Dec 22; 35(1-3):167-77. PubMed ID: 1955565 [Abstract] [Full Text] [Related]
10. Specificity of intrathecal IgG synthesis for HTLV-1 core and envelope proteins in HAM/TSP. Kitze B, Puccioni-Sohler M, Schäffner J, Rieckmann P, Weber T, Felgenhauer K, Bodemer W. Acta Neurol Scand; 1995 Sep 22; 92(3):213-7. PubMed ID: 7484074 [Abstract] [Full Text] [Related]
11. An inverse correlation of HTLV-I viral load in CSF and intrathecal synthesis of HTLV-I antibodies in TSP/HAM. Puccioni-Sohler M, Rios M, Bianco C, Zhu SW, Oliveira C, Novis SA, Pombo-de-Oliveira MS. Neurology; 1999 Oct 12; 53(6):1335-9. PubMed ID: 10522895 [Abstract] [Full Text] [Related]
13. Virological aspects of tropical spastic paraparesis/HTLV-I associated myelopathy and HTLV-I infection. Gessain A. J Neurovirol; 1996 Oct 12; 2(5):299-306. PubMed ID: 8912206 [Abstract] [Full Text] [Related]
14. Following the Clues: Usefulness of Biomarkers of Neuroinflammation and Neurodegeneration in the Investigation of HTLV-1-Associated Myelopathy Progression. Souza FDS, Freitas NL, Gomes YCP, Torres RC, Echevarria-Lima J, da Silva-Filho IL, Leite ACCB, de Lima MASD, da Silva MTT, Araújo AQC, Espíndola OM. Front Immunol; 2021 Oct 12; 12():737941. PubMed ID: 34764955 [Abstract] [Full Text] [Related]
17. Aquaporin-4 antibodies are not related to HTLV-1 associated myelopathy. von Glehn F, Jarius S, Penalva de Oliveira AC, Brandão CO, Farias AS, Damasceno A, Casseb J, Moraes AS, Longhini AL, Wandinger KP, Damasceno BP, Wildemann B, Santos LM. PLoS One; 2012 Oct 12; 7(7):e39372. PubMed ID: 22808032 [Abstract] [Full Text] [Related]
18. Human T-lymphotropic virus type I (HTLV-I)-specific antibodies and cell-free RNA in crevicular fluid-rich saliva from patients with tropical spastic paraparesis/HTLV-I-associated myelopathy. Soto-Ramirez LE, Garcia-Vallejo F, Renjifo B, Vergara A, Borrero I, Marlink R, Essex M. Viral Immunol; 1995 Oct 12; 8(3):141-50. PubMed ID: 8833267 [Abstract] [Full Text] [Related]